Revision endoscopic sinus surgery is rarely needed in dupilumab-treated chronic rhinosinusitis with nasal polyps

Key Points

• To evaluate the necessity of revision endoscopic sinus surgery (ESS) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with dupilumab.
• Evaluated the outcomes of patients with CRSwNP who underwent revision ESS after dupilumab treatment.
• Analyzed the effectiveness of dupilumab in controlling symptoms in this patient group.
• Revision ESS was rarely needed for patients treated with dupilumab for CRSwNP.
• Disappointing results were observed in patients who underwent revision ESS after failing dupilumab treatment.